Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2026)

Treace Medical Concepts has reported Cash & Current Investments for 7 years, with the latest figure at $51.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 31.85% year-over-year to $51.9 million; the trailing twelve-month figure through Mar 2026 stood at $51.9 million (down 31.85% YoY), and the FY2025 full-year result was $48.4 million, down 36.09% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $51.9 million, up from $48.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $170.7 million in Q1 2023, with the low at $48.4 million in Q4 2025.
• Historically, Cash & Current Investments has averaged $94.0 million across 5 years, with a median of $88.9 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 507.25% — and 2024, when it sank 38.57%.
• Treace Medical Concepts' Cash & Current Investments stood at $81.3 million in 2022, then jumped by 51.62% to $123.2 million in 2023, then slumped by 38.57% to $75.7 million in 2024, then sank by 36.09% to $48.4 million in 2025, then grew by 7.21% to $51.9 million in 2026.
• The last three Cash & Current Investments figures came in at $51.9 million (Q1 2026), $48.4 million (Q4 2025), and $57.4 million (Q3 2025), per Business Quant data.